Asahi Life Asset Management CO. LTD. bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,310 shares of the medical equipment provider’s stock, valued at approximately $712,000.
A number of other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Invesco Ltd. lifted its holdings in Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Northern Trust Corp lifted its holdings in Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after buying an additional 11,988 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Nuveen LLC bought a new position in Intuitive Surgical during the 1st quarter worth approximately $1,715,899,000. Institutional investors own 83.64% of the company’s stock.
Insider Transactions at Intuitive Surgical
In related news, EVP Myriam Curet sold 125 shares of the firm’s stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $543.00, for a total value of $67,875.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 96,011 shares of company stock worth $50,309,042 over the last quarter. Insiders own 0.70% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Price Performance
ISRG opened at $548.55 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market cap of $196.64 billion, a P/E ratio of 72.56, a P/E/G ratio of 4.94 and a beta of 1.61. The stock’s 50 day moving average price is $468.68 and its 200 day moving average price is $499.90.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the firm earned $1.84 EPS. The firm’s revenue was up 22.9% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- What is Short Interest? How to Use It
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Vertical Aerospace Stock Could Double After This Flight Test
- What Do S&P 500 Stocks Tell Investors About the Market?
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
